Fairscale Capital’s Pfizer PFE Stock Holding History

Fairscale Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79K	Hold	3,280	–	–	0.05%	168
2026 Q1	$92.1K	Hold	3,280	–	–	0.06%	151
2025 Q4	$81.7K	Hold	3,280	–	–	0.05%	154
2025 Q3	$83.6K	Hold	3,280	–	–	0.06%	156
2025 Q2	$76.4K	Hold	3,280	–	–	0.06%	159
2025 Q1	$83.1K	Sell	3,280 -430	-12%	-$11.3K	0.08%	136
2024 Q4	$98.4K	Sell	3,710 -2,369	-39%	-$64.3K	0.08%	121
2024 Q3	$176K	Hold	6,079	–	–	0.15%	82
2024 Q2	$179K	Buy	+6,079	New	+$167K	0.16%	80

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fairscale Capital's PFE Position: Q2 2026 in Review

Fairscale Capital held its Pfizer (PFE) position steady in Q2 2026 at 3,280 shares worth $79K. The position accounts for 0.05% of the portfolio, ranked #168.

Fairscale Capital first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $179K in Q2 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Fairscale Capital held 3,280 shares of Pfizer worth $79K as of Q2 2026.
Fairscale Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.05% of Fairscale Capital's portfolio in Q2 2026, its #168 holding.
Fairscale Capital first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Fairscale Capital's Pfizer position peaked at $179K in Q2 2024.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.